Indefinite Delivery Contract 75N95024D00012
Award Date
5/15/24
Last Date to Order
5/14/31
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Mriglobal
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Concept To Market LLC, a self-certified small disadvantaged business. The contract has a potential value of $49,713,679 and a period of performance through May 14, 2031. The contract provides Chemistry, Manufacturing, and Controls (CMC) services to support the NCATS Division of Preclinical Innovation (DPI)...
The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology...
The U.S. National Center for Advancing Translational Sciences (NCATS) has awarded an indefinite delivery contract (IDC) with a ceiling value of $49,885,703.00 to Purdue University to provide Chemistry, Manufacturing, and Control (CMC) services for the development of drug products. This multiple-award contract has an ultimate completion date of July 31, 2031. The scope of the contract includes a broad range of preclinical services required for the design, development, manufacture, and release...
The federal contract IDV award is for Chemistry, Manufacturing, and Control (CMC) and related services to support the development of drug products for the National Center for Advancing Translational Sciences (NCATS), a civilian agency. This is a multiple award, indefinite delivery contract with a $49,885,703 ceiling value and a period of performance through July 2031. The prime contractor, Alchem Laboratories Corporation, is a for-profit pharmaceutical manufacturer that will provide a broad...
This Indefinite Delivery Contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to the prime contractor Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The IDC, with a ceiling value of $17,891,012, is to provide CRO (Contract Research Organization) support for NCATS' Medicinal Chemistry for Lead Optimization program. This includes services...
This federal Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $49,990,000 single-award IDC has an ultimate completion date of June 30, 2028 and does not have a set-aside designation. Under this IDC, Mriglobal is providing a range of scientific research, testing, and product...
This is an Indefinite Delivery Contract (IDC) awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Advanced Bioscience Laboratories, Inc. (ABL) for Chemistry, Manufacturing and Controls (CMC) and related services to support the development of drug substances. The contract has a potential value of $49,713,679 and a period of performance from May 15, 2024 to May 14, 2031. It is a multiple award...
This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Alchem Laboratories Corporation. The contract, valued at up to $17,891,012, is to provide CRO (contract research organization) support services for NCATS's Medicinal Chemistry for Lead Optimization program. Under this multiple-award IDC, Alchem Laboratories will perform a variety of preclinical and...
This is an indefinite-delivery/indefinite-quantity (IDIQ) contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Bachem Americas, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical ingredients. The contract, valued up to $49.7M, is for Chemistry, Manufacturing, and Controls (CMC) services to support NCATS' drug development programs, including the production of active...